Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives
ChemMedChem · 2026
DOI: 10.1002/cmdc.70493 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2026. Verfasst von Christian S Carnero Canales und 7 weiteren Autor:innen. Beteiligte Einrichtung: BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, L…. Hauptthemen laut MEDLINE: Leishmaniasis, Malaria, Peptides, Nanoparticles. Die Arbeit nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Program for Scientific Research and Advanced Studies, Interinstitutional Alliances for Doctoral Programs, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Malaria and leishmaniasis continue to impose a substantial health burden, while current therapeutic and diagnostic strategies remain limited by toxicity, prolonged regimens, drug resistance, and restricted field applicability. This review examines recent advances in peptide‐enabled nanoplatforms for both diseases, with emphasis on intracellular targeting, drug delivery, and diagnostic innovation. Antimicrobial peptides, cell‐penetrating peptides, peptoids, mimotopes, and peptide‐functionalized nanocarriers have been explored to improve parasite targeting, intracellular delivery, pharmacokinetics, and antiparasitic efficacy. In parallel, peptide‐ and aptamer‐based nanosensors have expanded the detection of clinically relevant biomarkers, including HRP2, pLDH, GP63, KMP‐11, and kDNA, highlighting their potential for sensitive and modular diagnostics. Despite these advances, translation remains constrained by limited in vivo validation, insufficient pharmacokinetic standardization, incomplete toxicity profiling, poor batch reproducibility, protein corona‐associated variability, and scarce validation under field‐relevant conditions. Peptide‐enabled nanoplatforms are therefore most likely to succeed when aligned with stage‐specific parasite biology, realistic host cell‐targeting requirements, and scalable implementation pathways in endemic settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BIOMET Laboratorio de Química Bioinorgánica en Medicina, Medioambiente y Tecnología, Facultad de Ciencias de la Universidad Nacional de Ingeniería, Lima, Peru.
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil.
- General humanidades, Universidad Continental (UC), Arequipa, Perú.
- School of Pharmacy, Biochemistry and Biotechnology, Universidad Católica Santa María (UCSM), Arequipa, Perú.
ORCID-Profile: Christian S Carnero Canales, Ana Clara Lunardi Yagi, Túlio Custódio Reis, Jessica Ingrid Cazorla, Fernando Rogério Pavan
Förderung
- National Program for Scientific Research and Advanced Studies
- Interinstitutional Alliances for Doctoral Programs
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Carnero Canales, C. S., Lunardi Yagi, A. C., Reis, T. C., Cazorla, J. I., Rojas Villar, J., Graminha, M. A., Pastrana Alta, R. Y., & Pavan, F. R. (2026). Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. https://doi.org/10.1002/cmdc.70493
Vancouver
Carnero Canales CS, Lunardi Yagi AC, Reis TC, Cazorla JI, Rojas Villar J, Graminha MA, et al. Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives. ChemMedChem. 2026. doi:10.1002/cmdc.70493
BibTeX
@article{CarneroCanales2026,
author = {Carnero Canales, Christian S and Lunardi Yagi, Ana Clara and Reis, Túlio Custódio and Cazorla, Jessica Ingrid and Rojas Villar, Jade and Graminha, Marcia A and Pastrana Alta, Roxana Yesenia and Pavan, Fernando Rogério},
title = {Peptide‐Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.70493}
}
EUVIMED